- According to Transparency Market Research’s latest report on the global diagnostic specialty antibody market for the historical period 2017–2018 and forecast period 2019–2027, advancements in antibody development technology have revolutionized the diagnostic science through which antibodies can be produced against any pathogenic antigen and transformed the diagnostic industry.
- According to the report, the global diagnostic specialty antibody market was valued at US$ 22.6 Bn in 2018 and is anticipated to expand at a CAGR of 5.3% from 2019 to 2027
To know the scope of our report Get a Sample on Diagnostic Specialty Antibodies Market?
Increase in Reported Cases of Diagnostic Specialty Antibody: A Key Driver
- Increase in clinical research, evolution of infectious diseases, and unhealthy lifestyle of the population has led to innovation of new biological drugs as well as diagnostic kits. Several biotechnology and biopharmaceutical companies offer different diagnostic assays to meet the unmet medical needs of the health care system, which augment the diagnostic specialty antibody market.
- In 2014, Epitope Diagnostics, Inc. launched a new set of monoclonal antibody MMAE-ADC and MMAF-ADC ELISA kits, which are specific to detecting monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF), the two anti-cancer compounds. Launch of such innovative antibody based diagnostic kits is likely to enable the measurement of the disease condition more accurately. This is likely to increase interest of diagnostic laboratories and hospitals to use these products, which are likely ti augment the growth of diagnostic specialty antibody market
- Governments of several countries are investing in diagnostic health care. According to the World Bank, global healthcare expenditure was 6% of GDP. In 2016, world health care expenditure was US$ 6.5 Trn. In 2015, health care spending in the U.S. increased by 5.8% to reach US$ 3.2 Trn. The overall share of the U.S. economy devoted to health care spending was 17.8% in 2015, up from 17.4% in 2014. In 2015, total government health care expenditure in Europe was 7.2% of GDP.
- With respect to government investment in developing antibody-based diagnostic kits, in February 2018, the Bio & Medical Technology Development Program of the National Research Foundation of Korea developed a rapid diagnostic test kit to detect IgG and IgM antibody against Zika virus using monoclonal antibodies and the whole research was funded by the Government of South Korea, likely to drive the diagnostic specialty antibody market.
Get a glimpse of the in-depth analysis through our Report Brochure
Failure of Antibodies in Rapid Diagnostic Test for Routine Diagnosis to Hamper Global Diagnostic Specialty Antibody Market
- The Ministry of Health and Family Welfare, Government of India, indicated that the use of antibody detecting rapid diagnostic test (ADRDTs) is not the solution to diagnosis of diseases such as malaria, because serelogical testing is not practical for routine diagnosis of an acute parasite infectious disease in terms of the time required for development of antibody. Moreover, in endemic areas of India, the antibody detecting rapid diagnostic test gave false positive test results, as patients suffer due to other reasons. Hence, from March 2018, the Ministry of Health and Family Welfare, prohibited the use of antibody detecting rapid diagnostic tests for routine diagnosis of malaria. Such incidences are projected to hamper the growth of the diagnostic specialty antibody market.
North America to Account for Major Share of Global Diagnostic specialty antibody Market
- North America leads the global diagnostic specialty antibody market commanding more than 40% share in the global diagnostic specialty antibody market. Recent advances in diagnostic specialty antibody diagnostics, reimbursement for disease screening, and improved access to diagnostics are the major drivers of the diagnostic specialty antibody market in North America. U.S. is expected to hold major share in the North America diagnostic specialty antibody market during the forecast period, owing to developed health care infrastructure in the region and large patient population along with increasing technological development.
- Increase in government intervention in the emerging markets has led to rise in awareness about diseases and improvement in the health care infrastructure. Additionally, socioeconomic development has been observed in emerging economies such as Asia, Africa, and Latin America. These factors contribute to the overall increase in spending capacity of the population which likely expect to increase market share of Asia, Africa, and Latin America diagnostic specialty antibody market.
- Moreover, prevalence of life threatening diseases and infectious diseases such as COVID-19 is high in these regions. According to the WHO estimates, 4.2 million cases were detected till May 13 2020, with nearly 2.9 lakh COVID-19 related deaths. The number of COVID cases is expected to increase across the globe, with 50% of cases in Africa, Asia, and Latin America. Hence, increase in investment in these emerging markets is a major opportunity for key players, and these are anticipated to be major markets for diagnostic specialty antibody infection.
Expanding operations in future? To get the perfect launch ask for a custom report
Global Diagnostic Specialty Antibody Market: Competitive Landscape
- This report profiles major players in the global diagnostic specialty antibody market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
- Key players operating in the global diagnostic specialty antibody market include Abcam plc, Sanofi, Abbott laboratories, Hoffmann-La Roche Ltd., Danaher Corporation, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., and Aytu BioScience, Inc.
- Leading players operating in the global diagnostic specialty antibody market are
- F. Hoffmann-La Roche Ltd
- Sanofi
- Abbott Laboratories.
- These players offer products with proprietary technologies. Others include
- Abcam plc
- Bio-Rad Laboratories, Inc.
- Boehringer Ingelheim International GmbH
- Agilent Technologies, Inc.
- Aytu BioScience, Inc.
- Aytu Bioscience, Inc.
- invests in research and developmental activities to develop new and innovative products. It recently acquired and anticipates to commercialize FDA-approved ProstaScint (capromab pendetide), a radiolabeled monoclonal antibody. In January 2016, the company acquired a high-performance analytical flow cytometer platform from Propel Labs. This enables advanced and novice users to perform basic and multi-parameter cytometry for a wide range of applications and chemistries.
Global Diagnostic Specialty Antibody Market: Key Developments
High unmet needs in the global diagnostic specialty antibody market present lucrative opportunities for existing players and new entrants. For instance, Abcam plc plans to strengthen its position in Asia, specifically in China, to increase market share in unpenetrated segments and offer custom products and licensing. Additionally, in November 2016, Roche launched the global cancer immunotherapy Centers of Research Excellence (imCORE) network which brings together world’s leading scientific and clinical experts in cancer immunotherapy to collaborate in investigating promising new treatment approaches. The company announced investment up to CHF 100 Mn (US$ 98 Mn) to support basic and clinical research collaborations related to cancer immunotherapy.
The report on the global diagnostic specialty antibody market discusses individual strategies followed by company profiles of manufacturers of diagnostic specialty antibody treatment products. The competitive landscape section has been included in the diagnostic specialty antibody market report to provide readers with a dashboard view and a company diagnostic specialty antibody market share analysis of key players operating in the global diagnostic specialty antibody market.
TMR’s report on the global diagnostic specialty antibody market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period 2019–2027. The report provides the revenue of the global diagnostic specialty antibody market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global diagnostic specialty antibody market during the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global diagnostic specialty antibody market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global diagnostic specialty antibody market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global diagnostic specialty antibody market. These indices serve as valuable tools for existing players in the diagnostic specialty antibody market as well as for entities interested in entering the global market.
The report delves into the competitive landscape of the global diagnostic specialty antibody market. Key players operating in the global diagnostic specialty antibody market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global Diagnostic Specialty Antibody market that have been profiled in this report.
Global Diagnostic Specialty Antibody Market – Segmentation
|
Antibody Type |
End-user |
Application |
Region |
|
Monoclonal Antibodies |
Hospitals |
Hepatitis Diagnosis |
North America |
|
Polyclonal Antibodies |
Diagnostic Laboratories |
Tuberculosis Diagnostics |
Europe |
|
Recombinant Polyclonal Antibodies |
Others |
Dengue Diagnostics |
Asia Pacific |
|
|
|
Oncology Diagnostics |
Latin America |
|
|
|
HIV Diagnostics |
Middle East & Africa |
|
|
|
Infectious Disease Diagnostics |
|
|
|
|
Others Diagnostics |
|
Key Questions Answered in Global Diagnostic Specialty Antibody Market Report
- What is the scope of growth of product companies in the global diagnostic specialty antibody market?
- What will be the Y-o-Y growth of the global diagnostic specialty antibody market between 2019 and 2027?
- What is the influence of changing trends in antibodies on the global diagnostic specialty antibody market?
- Will North America continue to be the most profitable market for providers of diagnostic specialty antibody treatment products?
- Which factors will hamper the growth of the global diagnostic specialty antibody market during the forecast period?
- Which are the leading companies in the global diagnostic specialty antibody market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global diagnostic specialty antibody market and arrive at conclusions on the growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred by analysts during the production of the global diagnostic specialty antibody market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the global diagnostic specialty antibody market as primary sources.
These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from leaders in the diagnostic specialty antibody market. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global diagnostic specialty antibody market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and two bottom-up approaches to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global diagnostic specialty antibody market more reliably and accurately.
Regional Segmentation of Global Diagnostic Specialty Antibody Market
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Europe
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
The global diagnostic specialty antibodies market has been segmented as follows:
|
Antibody Type |
|
|
Application |
|
|
End-user |
|
|
Region |
|
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diagnostic Specialty Antibody Market
4. Market Overview
4.1. Introduction
4.1.1. Antibody Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diagnostic Specialty Antibody Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Disease Prevalence & Incidence Rate globally with key countries / Region
5.2. Pipeline Analysis
5.3. Key Industry Developments
6. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by Antibody Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Antibody Type, 2017–2027
6.3.1. Monoclonal Antibodies
6.3.2. Polyclonal Antibodies
6.3.3. Recombinant Polyclonal Antibodies
6.4. Market Attractiveness, by Antibody Type
7. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2027
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2027
8.3.1. Hepatitis Diagnosis
8.3.2. Tuberculosis Diagnostics
8.3.3. Dengue Diagnostics
8.3.4. Oncology Diagnostics
8.3.5. HIV Diagnostics
8.3.6. Infectious Disease Diagnostics
8.3.7. Others Diagnostics
8.4. Market Attractiveness Analysis, by Application
9. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Diagnostic Specialty Antibody Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Antibody Type, 2017–2027
10.2.1. Monoclonal Antibodies
10.2.2. Polyclonal Antibodies
10.2.3. Recombinant Polyclonal Antibodies
10.3. Market Value Forecast, by End-user, 2017–2027
10.3.1. Hospitals
10.3.2. Diagnostic Laboratories
10.3.3. Others
10.4. Market Value Forecast, by Application, 2017–2027
10.4.1. Hepatitis Diagnosis
10.4.2. Tuberculosis Diagnostics
10.4.3. Dengue Diagnostics
10.4.4. Oncology Diagnostics
10.4.5. HIV Diagnostics
10.4.6. Infectious Disease Diagnostics
10.4.7. Others Diagnostics
10.5. Market Value Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Antibody Type
10.6.2. By End-user
10.6.3. By Application
10.6.4. By Country
11. Europe Diagnostic Specialty Antibody Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Antibody Type, 2017–2027
11.2.1. Monoclonal Antibodies
11.2.2. Polyclonal Antibodies
11.2.3. Recombinant Polyclonal Antibodies
11.3. Market Value Forecast, by End-user, 2017–2027
11.3.1. Hospitals
11.3.2. Diagnostic Laboratories
11.3.3. Others
11.4. Market Value Forecast, by Application, 2017–2027
11.4.1. Hepatitis Diagnosis
11.4.2. Tuberculosis Diagnostics
11.4.3. Dengue Diagnostics
11.4.4. Oncology Diagnostics
11.4.5. HIV Diagnostics
11.4.6. Infectious Disease Diagnostics
11.4.7. Others Diagnostics
11.5. Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Antibody Type
11.6.2. By End-user
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Diagnostic Specialty Antibody Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Antibody Type, 2017–2027
12.2.1. Monoclonal Antibodies
12.2.2. Polyclonal Antibodies
12.2.3. Recombinant Polyclonal Antibodies
12.3. Market Value Forecast, by End-user, 2017–2027
12.3.1. Hospitals
12.3.2. Diagnostic Laboratories
12.3.3. Others
12.4. Market Value Forecast, by Application, 2017–2027
12.4.1. Hepatitis Diagnosis
12.4.2. Tuberculosis Diagnostics
12.4.3. Dengue Diagnostics
12.4.4. Oncology Diagnostics
12.4.5. HIV Diagnostics
12.4.6. Infectious Disease Diagnostics
12.4.7. Others Diagnostics
12.5. Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Antibody Type
12.6.2. By End-user
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Diagnostic Specialty Antibody Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Antibody Type, 2017–2027
13.2.1. Monoclonal Antibodies
13.2.2. Polyclonal Antibodies
13.2.3. Recombinant Polyclonal Antibodies
13.3. Market Value Forecast, by End-user, 2017–2027
13.3.1. Hospitals
13.3.2. Diagnostic Laboratories
13.3.3. Others
13.4. Market Value Forecast, by Application, 2017–2027
13.4.1. Hepatitis Diagnosis
13.4.2. Tuberculosis Diagnostics
13.4.3. Dengue Diagnostics
13.4.4. Oncology Diagnostics
13.4.5. HIV Diagnostics
13.4.6. Infectious Disease Diagnostics
13.4.7. Others Diagnostics
13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Antibody Type
13.6.2. By End-user
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Diagnostic Specialty Antibody Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Antibody Type, 2017–2027
14.2.1. Monoclonal Antibodies
14.2.2. Polyclonal Antibodies
14.2.3. Recombinant Polyclonal Antibodies
14.3. Market Value Forecast, by End-user, 2017–2027
14.3.1. Hospitals
14.3.2. Diagnostic Laboratories
14.3.3. Others
14.4. Market Value Forecast, by Application, 2017–2027
14.4.1. Hepatitis Diagnosis
14.4.2. Tuberculosis Diagnostics
14.4.3. Dengue Diagnostics
14.4.4. Oncology Diagnostics
14.4.5. HIV Diagnostics
14.4.6. Infectious Disease Diagnostics
14.4.7. Others Diagnostics
14.5. Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Antibody Type
14.6.2. By End-user
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share/Position Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. Abcam plc
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Growth Strategies
15.3.1.3. SWOT Analysis
15.3.2. F. Hoffmann-La Roche Ltd.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Growth Strategies
15.3.2.3. SWOT Analysis
15.3.3. Abbott Laboratories
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Growth Strategies
15.3.3.3. SWOT Analysis
15.3.4. Sanofi
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Growth Strategies
15.3.4.3. SWOT Analysis
15.3.5. Bio-Rad Laboratories, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Growth Strategies
15.3.5.3. SWOT Analysis
15.3.6. Boehringer Ingelheim International GmbH
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Growth Strategies
15.3.6.3. SWOT Analysis
15.3.7. Agilent Technologies, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Growth Strategies
15.3.7.3. SWOT Analysis
15.3.8. Aytu BioScience, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
List of Tables
Table 01: Pipeline Analysis of Diagnostic Specialty Antibody (1/2)
Table 02: Pipeline Analysis of Diagnostic Specialty Antibody (2/2)
Table 03: Global Diagnostic Specialty Antibody Market Size (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 04: Global Diagnostic Specialty Antibody Market Size (US$ Mn) Forecast, by Application, 2017–2027
Table 05: Global Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: Global Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 08: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 09: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 10: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 11: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2027
Table 12: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 13: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 14: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 15: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/ Sub-Region, 2017–2027
Table 16: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 17: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 18: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 19: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 21: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 22: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 23: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 25 : Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 26: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
List of Figures
Figure 01: Global Diagnostic Specialty Antibody Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Market Snapshot of Global Diagnostic Specialty Antibody Market
Figure 03: Market Opportunity Map, Revenue Share, by Antibody Type
Figure 04: Market Opportunity Map, Revenue Share, by Application
Figure 05: Recent Key Industry Events of Diagnostic Specialty Antibody Market
Figure 06: Global Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, 2017–2027
Figure 07: Market Value Share, by End-user, 2017
Figure 08: Market Value Share, by Antibody Type, 2017
Figure 09: Market Value Share, by Region, 2017
Figure 10: Market Value Share, by Application, 2017
Figure 11: Patent Filling Details of Various Diagnostic Antibody
Figure 12: Patent Filling Details of Various Diagnostic Antibody
Figure 13: Patent Filling Details of Various Diagnostic Antibody
Figure 14 : Global Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 15: Global Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 16: Global Monoclonal Antibodies Market Revenue
Figure 17: Global Polyclonal Antibodies Market Revenue
Figure 18: Global Recombinant Polyclonal Antibodies Market Revenue
Figure 19: Global Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 20: Global Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 21: Global Hepatitis Diagnostic Specialty Antibody Market Revenue
Figure 22: Global Tuberculosis Diagnostic Specialty Antibody Market Revenue
Figure 23: Global Dengue Diagnostic Specialty Antibody Market Revenue
Figure 24: Global Oncology Diagnostics Diagnostic Specialty Antibody Market Revenue
Figure 25: Global HIV Diagnostics Diagnostic Specialty Antibody Market Revenue
Figure 26: Global Infectious Disease Diagnostics Diagnostic Specialty Antibody Market Revenue
Figure 27: Global Other Diagnostics Diagnostic Specialty Antibody Market Revenue
Figure 28: Global Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 29: Global Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
Figure 30: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017–2027
Figure 31: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2017–2027
Figure 32: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 32: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 33: Global Diagnostic Specialty Antibody Market Value Share, by Region, 2018 and 2027
Figure 34: Global Diagnostic Specialty Antibody Market Attractiveness, by Region, 2019–2027
Figure 35: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 36: North America Diagnostic Specialty Antibody Market Value Share, by Country, 2018 and 2027
Figure 37: North America Diagnostic Specialty Antibody Market Attractiveness, by Country, 2019–2027
Figure 38: North America Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 39: North America Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 40: North America Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 41: North America Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 42: North America Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 43: North America Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
Figure 44: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 45: Europe Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027
Figure 46: Europe Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 47: Europe Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 48: Europe Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 49: Europe Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 50: Europe Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 51: Europe Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 52: Europe Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
Figure 53: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 54: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027
Figure 55: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 56: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 57: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 58: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 59: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 60: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 61: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
Figure 62: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 63: Latin America Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027
Figure 64: Latin America Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 65: Latin America Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 66: Latin America Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 67: Latin America Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 68: Latin America Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 69: Latin America Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 70: Latin America Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
Figure 71: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 72: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027
Figure 73: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 74: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 75: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 76: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 77: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 78: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 79: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
